Product Information
CRESTOR 5 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $8.8180 per EA under NDC 00310756090. Its NADAC has been published 177 times since Jun 29, 2022.
The High Outlier badge above means this manufacturer's average price in the Rosuvastatin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310756090
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
New Drug (NDA)
FDA Application
NDA021366On Market Since
5/9/2022
Pharmacological Classes
Price Statistics
The NADAC for CRESTOR 5 MG TABLET has been published 177 times since Jun 29, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8180 per EA |
|---|---|
| All-time high | $8.8632 (Jan 15, 2025) |
| All-time low | $8.8156 (Mar 18, 2026) |
| 52-week high | $8.8482 |
| 52-week low | $8.8156 |
| Median price | $8.8410 |
| Average price | $8.8424 |
| Largest weekly change | +0.3% (Apr 17, 2024) |
| Weeks tracked | 177 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CRESTOR 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CRESTOR 5 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $8.8180 per EA (NDC 00310756090), effective Jun 24, 2026.
How has the price of CRESTOR 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CRESTOR 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 177 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CRESTOR 5 MG TABLET?
Since Jun 29, 2022, the NADAC for CRESTOR 5 MG TABLET has ranged from a low of $8.8156 (Mar 18, 2026) to a high of $8.8632 (Jan 15, 2025), with a median of $8.8410 per EA.
Are there cheaper alternatives to CRESTOR 5 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 5 MG TAB, is $0.0348 per EA — about 100% below CRESTOR 5 MG TABLET.
Who manufactures CRESTOR 5 MG TABLET?
CRESTOR 5 MG TABLET (NDC 00310756090) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification